Mast cells in the development of adaptive immune responses - Nature Immunology
- ️Tsai, Mindy
- ️Thu Jan 20 2005
Kitamura, Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu. Rev. Immunol. 7, 59–76 (1989).
Metcalfe, D.D., Baram, D. & Mekori, Y.A. Mast cells. Physiol. Rev. 77, 1033–1079 (1997).
Kawakami, T. & Galli, S.J. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2, 773–786 (2002).
Galli, S.J., Zsebo, K.M. & Geissler, E.N. The kit ligand, stem cell factor. Adv. Immunol. 55, 1–96 (1994).
Gonzalez-Espinosa, C. et al. Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J. Exp. Med. 197, 1453–1465 (2003).
Galli, S. et al. Mast cells as “tunable” effector and immunoregulatory cells: Recent advances. Annu. Rev. Immunol. 23, 749–786 (2005).
Kinet, J.P. The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annu. Rev. Immunol. 17, 931–972 (1999).
Blank, U. & Rivera, J. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol. 25, 266–273 (2004).
Nakano, T. et al. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J. Exp. Med. 162, 1025–1043 (1985).
Tsai, M., Tam, S.Y., Wedemeyer, J. & Galli, S.J. Mast cells derived from embryonic stem cells: a model system for studying the effects of genetic manipulations on mast cell development, phenotype, and function in vitro and in vivo. Int. J. Hematol. 75, 345–349 (2002).
Berrozpe, G. et al. The W(sh), W(57), and Ph Kit expression mutations define tissue-specific control elements located between -23 and -154 kb upstream of Kit. Blood 94, 2658–2666 (1999).
Hayashi, S., Kunisada, T., Ogawa, M., Yamaguchi, K. & Nishikawa, S. Exon skipping by mutation of an authentic splice site of c-kit gene in W/W mouse. Nucleic Acids Res. 19, 1267–1271 (1991).
Nocka, K. et al. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J. 9, 1805–1813 (1990).
Reith, A.D. et al. W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor. Genes Dev. 4, 390–400 (1990).
Yamazaki, M. et al. C-kit gene is expressed by skin mast cells in embryos but not in puppies of Wsh/Wsh mice: age-dependent abolishment of c-kit gene expression. Blood 83, 3509–3516 (1994).
Grimbaldeston, M.A., Chen, C.-C., Tam, S.-Y., Tsai, M. & Galli, S.J. Mast cell deficient W-sash c-kit mutant KitW-sh//KitW-sh mice as a model for investigating mast cell biology in vivo. FASEB J. (in the press).
Mallen-St Clair, J., Pham, C.T., Villalta, S.A., Caughey, G.H. & Wolters, P.J. Mast cell dipeptidyl peptidase I mediates survival from sepsis. J. Clin. Invest. 113, 628–634 (2004).
Stevens, J. & Loutit, J.F. Mast cells in spotted mutant mice (W Ph mi). Proc. R. Soc. Lond. B 215, 405–409 (1982).
Duttlinger, R. et al. W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis. Development 118, 705–717 (1993).
Maurer, M. et al. Mast cells promote homeostasis by limiting endothelin-1 induced toxicity. Nature 432, 512–516 (2004).
Lantz, C.S. et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392, 90–93 (1998).
King, C.L. et al. Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni. J. Immunol. 158, 294–300 (1997).
Strait, R.T., Morris, S.C., Yang, M., Qu, X.W. & Finkelman, F.D. Pathways of anaphylaxis in the mouse. J. Allergy Clin. Immunol. 109, 658–668 (2002).
Williams, C.M. & Galli, S.J. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J. Exp. Med. 192, 455–462 (2000).
Kobayashi, T. et al. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J. Immunol. 164, 3855–3861 (2000).
Woolhiser, M.R., Brockow, K. & Metcalfe, D.D. Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a. Clin. Immunol. 110, 172–180 (2004).
Marshall, J.S. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4, 787–799 (2004).
Galli, S.J., Tsai, M. & Chatterjea, D. in The Innate Immune Response to Infection (eds. Kaufman, S.H.E., Medzhitov, R. & Gordon, S.) 111–132 (ASM Press, Berlin, 2004).
Di Nardo, A., Vitiello, A. & Gallo, R.L. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 170, 2274–2278 (2003).
Malaviya, R. et al. Mast cell phagocytosis of FimH-expressing enterobacteria. J. Immunol. 152, 1907–1914 (1994).
Malaviya, R., Twesten, N.J., Ross, E.A., Abraham, S.N. & Pfeifer, J.D. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J. Immunol. 156, 1490–1496 (1996).
Mekori, Y.A. & Metcalfe, D.D. Mast cell-T cell interactions. J. Allergy Clin. Immunol. 104, 517–523 (1999).
Henz, B.M., Maurer, M., Lippert, U., Worm, M. & Babina, M. Mast cells as initiators of immunity and host defense. Exp. Dermatol. 10, 1–10 (2001).
Frandji, P. et al. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes. Eur. J. Immunol. 26, 2517–2528 (1996).
Sayama, K. et al. Transcriptional response of human mast cells stimulated via the FcεRI and identification of mast cells as a source of IL-11. BMC Immunol. 3, 5 (2002).
Kashiwakura, J., Yokoi, H., Saito, H. & Okayama, Y. T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J. Immunol. 173, 5247–5257 (2004).
Skokos, D. et al. Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J. Immunol. 166, 868–876 (2001).
Wang, H.W., Tedla, N., Lloyd, A.R., Wakefield, D. & McNeil, P.H. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J. Clin. Invest. 102, 1617–1626 (1998).
Steinman, R.M. & Inaba, K. Myeloid dendritic cells. J. Leukoc. Biol. 66, 205–208 (1999).
Cumberbatch, M., Dearman, R.J., Griffiths, C.E. & Kimber, I. Langerhans cell migration. Clin. Exp. Dermatol. 25, 413–418 (2000).
Kaser, A. et al. A role for IL-16 in the cross-talk between dendritic cells and T cells. J. Immunol. 163, 3232–3238 (1999).
Cumberbatch, M., Dearman, R.J., Antonopoulos, C., Groves, R.W. & Kimber, I. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-α- and IL-1β-dependent mechanism. Immunology 102, 323–330 (2001).
Sozzani, S. et al. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol. 155, 3292–3295 (1995).
Yamazaki, S., Yokozeki, H., Satoh, T., Katayama, I. & Nishioka, K. TNF-alpha, RANTES, and MCP-1 are major chemoattractants of murine Langerhans cells to the regional lymph nodes. Exp. Dermatol. 7, 35–41 (1998).
Carramolino, L. et al. Down-regulation of the beta-chemokine receptor CCR6 in dendritic cells mediated by TNF-α and IL-4. J. Leukoc. Biol. 66, 837–844 (1999).
Robbiani, D.F. et al. The leukotriene C4 transporter MRP1 regulates CCL19 (MIP-3β, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103, 757–768 (2000).
Kabashima, K. et al. Prostaglandin E2–EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9, 744–749 (2003).
Ioffreda, M.D., Whitaker, D. & Murphy, G.F. Mast cell degranulation upregulates α6 integrins on epidermal Langerhans cells. J. Invest. Dermatol. 101, 150–154 (1993).
Skokos, D. et al. Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J. Immunol. 170, 3037–3045 (2003).
Caron, G. et al. Histamine induces CD86 expression and chemokine production by human immature dendritic cells. J. Immunol. 166, 6000–6006 (2001).
Mazzoni, A., Young, H.A., Spitzer, J.H., Visintin, A. & Segal, D.M. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J. Clin. Invest. 108, 1865–1873 (2001).
Caron, G. et al. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J. Immunol. 167, 3682–3686 (2001).
Kalinski, P., Hilkens, C.M., Snijders, A., Snijdewint, F.G. & Kapsenberg, M.L. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159, 28–35 (1997).
Faveeuw, C. et al. Prostaglandin D2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways. Eur. J. Immunol. 33, 889–898 (2003).
Gosset, P. et al. Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J. Immunol. 170, 4943–4952 (2003).
Soumelis, V. et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 3, 673–680 (2002).
Ikeda, K. et al. Mast cells produce interleukin-25 upon FcεRI-mediated activation. Blood 101, 3594–3596 (2003).
Fort, M.M. et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15, 985–995 (2001).
Bryce, P.J. et al. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 20, 381–392 (2004).
Jawdat, D.M., Albert, E.J., Rowden, G., Haidl, I.D. & Marshall, J.S. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J. Immunol. 173, 5275–5282 (2004).
Mekori, Y.A. The mastocyte: the “other” inflammatory cell in immunopathogenesis. J. Allergy Clin. Immunol. 114, 52–57 (2004).
Nakajima, T. et al. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcεreceptor I cross-linking: an interspecies comparison. Blood 100, 3861–3868 (2002).
Lin, T.J. et al. Selective early production of CCL20, or macrophage inflammatory protein 3α, by human mast cells in response to Pseudomonas aeruginosa. Infect. Immun. 71, 365–373 (2003).
Mori, Y. et al. Tyk2 is essential for IFN-α-induced gene expression in mast cells. Int. Arch. Allergy Immunol. 134, 25–29 (2004).
Ott, V.L., Cambier, J.C., Kappler, J., Marrack, P. & Swanson, B.J. Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4 . Nat. Immunol. 4, 974–981 (2003).
Jutel, M. et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413, 420–425 (2001).
McLachlan, J.B. et al. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat. Immunol. 4, 1199–1205 (2003).
Kawabe, T. et al. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167–178 (1994).
Xu, J. et al. Mice deficient for the CD40 ligand. Immunity 1, 423–431 (1994).
Gauchat, J.F. et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365, 340–343 (1993).
Pawankar, R., Okuda, M., Yssel, H., Okumura, K. & Ra, C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FcεRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J. Clin. Invest. 99, 1492–1499 (1997).
Yanagihara, Y. et al. Cultured basophils but not cultured mast cells induce human IgE synthesis in B cells after immunologic stimulation. Clin. Exp. Immunol. 111, 136–143 (1998).
Ryzhov, S. et al. Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. J. Immunol. 172, 7726–7733 (2004).
Yoshikawa, T., Imada, T., Nakakubo, H., Nakamura, N. & Naito, K. Rat mast cell protease-I enhances immunoglobulin E production by mouse B cells stimulated with interleukin-4. Immunology 104, 333–340 (2001).
Paul, W.E., Seder, R.A. & Plaut, M. Lymphokine and cytokine production by FcεRI+ cells. Adv. Immunol. 53, 1–29 (1993).
Stassen, M. et al. IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-κB is decisively involved in the expression of IL-9. J. Immunol. 166, 4391–4398 (2001).
Villa, I. et al. Capacity of mouse mast cells to prime T cells and to induce specific antibody responses in vivo. Immunology 102, 165–172 (2001).
Williams, C.M.M. & Galli, S.J. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J. Allergy Clin. Immunol. 105, 847–859 (2000).
Martin, T.R. et al. Mast cells contribute to the changes in heart rate, but not hypotension or death, associated with active anaphylaxis in mice. J. Immunol. 151, 367–376 (1993).
Alenius, H. et al. Mast cells regulate IFN-γ expression in the skin and circulating IgE levels in allergen-induced skin inflammation. J. Allergy Clin. Immunol. 109, 106–113 (2002).
Ha, T.Y., Reed, N.D. & Crowle, P.K. Immune response potential of mast cell-deficient W/Wv mice. Int. Arch. Allergy Appl. Immunol. 80, 85–94 (1986).
Martin, T.R., Galli, S.J., Katona, I.M. & Drazen, J.M. Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice. J. Clin. Invest. 83, 1375–1383 (1989).
Kung, T.T. et al. Mast cells modulate allergic pulmonary eosinophilia in mice. Am. J. Respir. Cell Mol. Biol. 12, 404–409 (1995).
Takeda, K. et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J. Exp. Med. 186, 449–454 (1997).
Askenase, P.W. et al. Defective elicitation of delayed-type hypersensitivity in W/Wv and Sl/Sld mast cell-deficient mice. J. Immunol. 131, 2687–2694 (1983).
Biedermann, T. et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192, 1441–1452 (2000).
Thomas, W.R. & Schrader, J.W. Delayed hypersensitivity in mast-cell-deficient mice. J. Immunol. 130, 2565–2567 (1983).
Galli, S.J. & Hammel, I. Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. Science 226, 710–713 (1984).
Wershil, B.K., Wang, Z.S., Gordon, J.R. & Galli, S.J. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J. Clin. Invest. 87, 446–453 (1991).
Furuta, G.T. et al. Mast cell-dependent tumor necrosis factor α production participates in allergic gastric inflammation in mice. Gastroenterology 113, 1560–1569 (1997).
Secor, V.H., Secor, W.E., Gutekunst, C.A. & Brown, M.A. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191, 813–822 (2000).
Robbie-Ryan, M., Tanzola, M.B., Secor, V.H. & Brown, M.A. Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J. Immunol. 170, 1630–1634 (2003).
Tanzola, M.B., Robbie-Ryan, M., Gutekunst, C.A. & Brown, M.A. Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol. 171, 4385–4391 (2003).
Pedotti, R. et al. An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide. Nat. Immunol. 2, 216–222 (2001).
Pedotti, R., De Voss, J.J., Steinman, L. & Galli, S.J. Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 24, 479–484 (2003).
Lee, D.M. et al. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297, 1689–1692 (2002).
Chen, R. et al. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J. Clin. Invest. 108, 1151–1158 (2001).